Guardian Pharmacy Services (NYSE:GRDN) Downgraded by Wall Street Zen to Buy

Wall Street Zen cut shares of Guardian Pharmacy Services (NYSE:GRDN) from a strong-buy rating to a buy rating in a report published on Saturday morning.

Several other analysts have also issued reports on GRDN. Raymond James Financial reissued an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Zacks Research raised shares of Guardian Pharmacy Services from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, March 18th. Oppenheimer boosted their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research report on Thursday. Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company a “buy” rating in a research report on Monday, April 13th. Finally, UBS Group reaffirmed a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $41.33.

Guardian Pharmacy Services Stock Down 0.7%

NYSE GRDN opened at $36.01 on Friday. The company’s 50 day moving average is $36.07 and its 200-day moving average is $32.28. Guardian Pharmacy Services has a 12-month low of $19.17 and a 12-month high of $41.36. The firm has a market cap of $1.79 billion, a P/E ratio of 43.39, a price-to-earnings-growth ratio of 2.40 and a beta of 0.09.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.05. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The company had revenue of $336.60 million for the quarter, compared to analyst estimates of $329.89 million. During the same quarter in the previous year, the firm posted $0.22 earnings per share. The company’s quarterly revenue was up 2.2% compared to the same quarter last year. Equities analysts expect that Guardian Pharmacy Services will post 1.17 EPS for the current year.

Insider Buying and Selling at Guardian Pharmacy Services

In related news, insider Kendall Forbes sold 346,672 shares of the company’s stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $29.68, for a total transaction of $10,289,224.96. Following the sale, the insider owned 453,256 shares of the company’s stock, valued at approximately $13,452,638.08. This represents a 43.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director John Ackerman sold 1,103,364 shares of the stock in a transaction on Friday, March 20th. The stock was sold at an average price of $29.68, for a total transaction of $32,747,843.52. Following the completion of the transaction, the director directly owned 345,123 shares in the company, valued at $10,243,250.64. The trade was a 76.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 9,726,405 shares of company stock worth $288,679,700 in the last ninety days. Insiders own 32.96% of the company’s stock.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors have recently made changes to their positions in the stock. State of Alaska Department of Revenue bought a new position in shares of Guardian Pharmacy Services in the 3rd quarter worth $30,000. Ameritas Investment Partners Inc. increased its holdings in shares of Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after buying an additional 345 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth $43,000. State of Wyoming bought a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth $58,000. Finally, Strs Ohio bought a new position in shares of Guardian Pharmacy Services in the 4th quarter worth $75,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.